List of insiders holdings for Avid Bioservices Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Green Nicholas Stewart President & CEO | 2024-10-11 19:37:48 | 1,718,447 0 | 1,718,447 | Form 4 |
| Masten Jeffrey L. V.P. Quality | 2013-05-08 20:28:09 | 614,103 0 | 614,103 | Form 4 |
| Waltz Thomas A Director | 2008-01-11 21:37:48 | 600,000 2,500 | 602,500 | Form 4 |
| Eastern Capital LTD Portfolio Services Ltd. DART KENNETH BRYAN 10% Owner | 2021-01-26 16:19:03 | 523,810 0 | 523,810 | Form 13G |
| SWARTZ ERIC S Director | 2017-08-29 17:16:25 | 511,788 0 | 511,788 | Form 4 |
| JOHNSON CARLTON M Director | 2017-08-29 17:15:39 | 493,444 0 | 493,444 | Form 4 |
| Hart Daniel R Chief Financial Officer | 2024-07-11 17:01:05 | 393,148 0 | 393,148 | Form 4 |
| Richieri Richard A. Chief Operations Officer | 2024-10-11 19:38:34 | 308,627 29,311 | 337,938 | Form 4 |
| POHL DAVID Director | 2017-08-29 17:16:02 | 262,305 0 | 262,305 | Form 4 |
| LYTLE PAUL J Chief Financial Officer | 2017-04-28 18:57:34 | 221,427 0 | 221,427 | Form 4 |
| Ziebell Mark R V. P., General Counsel | 2024-07-11 17:02:39 | 211,889 0 | 211,889 | Form 4 |
| Fussey Shelley PM V.P., Intellectual Property | 2016-11-01 19:58:31 | 161,341 0 | 161,341 | Form 4 |
| Carleone Joseph Director | 2023-12-18 19:30:26 | 130,324 0 | 130,324 | Form 4 |
| Walsh Patrick D Director | 2020-12-16 20:00:58 | 126,684 0 | 126,684 | Form 4 |
| Bamforth Mark R Director | 2021-03-19 17:25:17 | 0 126,000 | 126,000 | Form 4 |
| Hancock Richard B Director | 2024-01-10 19:56:02 | 117,563 0 | 117,563 | Form 4 |
| Kwietniak Matthew R. Chief Commercial Officer | 2024-10-15 19:40:21 | 100,519 0 | 100,519 | Form 4 |
| McComb Joel Director | 2018-12-18 20:22:17 | 94,600 0 | 94,600 | Form 4 |
| Hedberg Stephen Michael Principal Fin. & Acct. Officer | 2018-07-20 17:05:14 | 70,436 0 | 70,436 | Form 3 |
| Kinjerski Tracy VP, Business Operations | 2018-01-25 16:30:10 | 52,000 0 | 52,000 | Form 3 |
| Thoma Jeanne Director | 2023-12-18 19:34:08 | 45,611 0 | 45,611 | Form 4 |
| MACKEY CATHERINE J Director | 2023-12-18 19:32:11 | 43,379 0 | 43,379 | Form 4 |
| Alegria Esther M. Director | 2024-07-11 17:00:45 | 37,746 0 | 37,746 | Form 4 |
| SARGEN GREGORY Director | 2023-12-18 19:33:03 | 36,368 0 | 36,368 | Form 4 |
| KING STEVEN W President & CEO | 2017-11-01 15:12:05 | 36,044 0 | 36,044 | Form 4 |
| Shan Joseph VP, Clinical and Reg Affairs | 2017-11-01 15:13:41 | 18,934 0 | 18,934 | Form 4 |
| Lias Roger J. President & CEO | 2019-04-30 20:55:09 | 4,578 0 | 4,578 | Form 4 |
| LEGERE EDWARD J II Director | 2003-10-16 19:56:55 | 0 0 | 0 | Form 4 |
| King F David V.P., Business Development | 2009-10-23 17:34:12 | 0 0 | 0 | Form 4 |
| TAYLOR CLIVE R Director | 2004-10-25 18:15:22 | 0 0 | 0 | Form 4 |
| AJIT-SIMH KA VP Quality Assurance | 2004-01-08 20:53:22 | 0 0 | 0 | Form 4 |